We are live on
!
Find out more
MCM
Murphy Capital Management Portfolio holdings
AUM
$720M
1-Year Est. Return
9.22%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
-9.22%
3 Year Est. Return
+41.59%
5 Year Est. Return
+78.17%
10 Year Est. Return
–
AUM
$704M
AUM Growth
+$38.2M
(+5.7%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-1.93%
Top 10 Holdings %
Top 10 Hldgs %
29.08%
Holding
244
New
12
Increased
35
Reduced
139
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$921K |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$266K |
| 3 |
Chevron
CVX
|
+$247K |
| 4 |
ProShares UltraPro QQQ
TQQQ
|
+$223K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$220K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.75M |
| 2 |
Roper Technologies
ROP
|
+$1.28M |
| 3 |
Apple
AAPL
|
+$1.2M |
| 4 |
Kroger
KR
|
+$603K |
| 5 |
Essential Utilities
WTRG
|
+$579K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Industrials | 10.51% |
| 3 | Financials | 8.34% |
| 4 | Communication Services | 7.96% |
| 5 | Healthcare | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BMY.RT
226
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $47K | 0.01% |
+15,815
| New | +$41.1K |
|
|
MDVL
227
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $24K | ﹤0.01% |
34
| – | – |
|
228
BP
BP
$112B
| – | – |
-5,745
| Closed | -$218K |
|
|
DOG
229
ProShares Short Dow30
DOG
$111M
| – | – |
-4,500
| Closed | -$236K |
|
230
EOG Resources
EOG
$77.3B
| – | – |
-2,890
| Closed | -$214K |
|
|
231
Kroger
KR
$36.8B
| – | – |
-23,415
| Closed | -$603K |
|
232
Realty Income
O
$61.1B
| – | – |
-2,761
| Closed | -$205K |
|
233
Occidental Petroleum
OXY
$55.8B
| – | – |
-5,320
| Closed | -$236K |
|
234
Prudential Financial
PRU
$42.9B
| – | – |
-2,408
| Closed | -$216K |
|
235
Invesco Dorsey Wright Energy Momentum ETF
PXI
$58.5M
| – | – |
-9,569
| Closed | -$249K |
|
|
236
Roper Technologies
ROP
$40.2B
| – | – |
-3,600
| Closed | -$1.28M |
|
|
237
Essential Utilities
WTRG
$11.5B
| – | – |
-12,929
| Closed | -$579K |
|
238
Xylem
XYL
$28.6B
| – | – |
-5,235
| Closed | -$416K |
|
|
CELG
239
DELISTED
Celgene Corp
CELG
| – | – |
-17,635
| Closed | -$1.75M |
|
Similar funds
DHFB
TFM
BDWM
MWM
CP
BWM
FPS
IC
Murphy Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Murphy Capital Management held 244 positions worth $704M, up 5.7% from $665M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Murphy Capital Management's Q4 2019 filing shows 12 new, 35 increased, 139 reduced and 12 closed positions. Its largest new stake was ProShares UltraPro QQQ: 24,480 shares worth $264K. The largest sale was Celgene Corp, an estimated $1.75M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 9.9% a quarter earlier, followed by Industrials and Financials.
- Murphy Capital Management's largest Q4 2019 buy was ProShares UltraPro QQQ: 24,480 shares worth $264K.
- Murphy Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $921K increase.
- Murphy Capital Management's biggest Q4 2019 reduction was Apple, cutting an estimated $1.2M.
- Murphy Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.75M.
- Murphy Capital Management's ten largest holdings make up 29% of its $704M portfolio in Q4 2019.
- Murphy Capital Management opened 12 new positions and closed 12 in Q4 2019.
- Murphy Capital Management's portfolio value rose 5.7% quarter-over-quarter to $704M.
Based on Murphy Capital Management's 13F filing for Q4 2019, filed 10 Feb 2020.